RNA Analysis/Transcriptomics Trends and Forecast
The future of the global RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets. The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
RNA Analysis/Transcriptomics by Segment
The study includes a forecast for the global RNA analysis/transcriptomics by product type, technology, application, end use, and region.RNA Analysis/Transcriptomics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
- Consumables
- Instruments
- Software
- Services
RNA Analysis/Transcriptomics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
- Real Time-PCR (qPCR)
- Microarray
- Sequencing
- Others
RNA Analysis/Transcriptomics Market by Application [Shipment Analysis by Value from 2018 to 2030]:
- Drug Discovery
- Diagnostics & Disease Profiling
- Others
RNA Analysis/Transcriptomics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Government Institutes & Academic Centers
- Pharmaceutical & Biotechnology
- Hospitals & Clinics
- Contract Research Organizations (CROs)
- Others
RNA Analysis/Transcriptomics Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of RNA Analysis/Transcriptomics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies RNA analysis/transcriptomics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the RNA analysis/transcriptomics companies profiled in this report include-- Agilent Technologies
- F. Hoffmann-La Roche
- Illumina
- QIAGEN
- Thermo Fisher Scientific
- Eurofins Scientific
- Merck KGaA
- Bio-Rad Laboratories
- Pacific Bioscience of California
- Affymetrix
RNA Analysis/Transcriptomics Market Insights
The publisher forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.
Features of the Global RNA Analysis/Transcriptomics Market
- Market Size Estimates: RNA analysis/transcriptomics market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: RNA analysis/transcriptomics market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).
- Regional Analysis: RNA analysis/transcriptomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the RNA analysis/transcriptomics market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the RNA analysis/transcriptomics market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the RNA analysis/transcriptomics market size?Answer: The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030.
Q2. What is the growth forecast for RNA analysis/transcriptomics market?
Answer: The global RNA analysis/transcriptomics market is expected to grow with a CAGR of 10.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the RNA analysis/transcriptomics market?
Answer: The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.
Q4. What are the major segments for RNA analysis/transcriptomics market?
Answer: The future of the RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets.
Q5. Who are the key RNA analysis/transcriptomics market companies?
Answer: Some of the key RNA analysis/transcriptomics companies are as follows:
- Agilent Technologies
- F. Hoffmann-La Roche
- Illumina
- QIAGEN
- Thermo Fisher Scientific
- Eurofins Scientific
- Merck KGaA
- Bio-Rad Laboratories
- Pacific Bioscience of California
- Affymetrix
Answer: The publisher forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.
Q7. In RNA analysis/transcriptomics market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the RNA analysis/transcriptomics market by product type (consumables, instruments, software, and services), technology (real time-pcr (qPCR), microarray, sequencing, and others), application (drug discovery, diagnostics & disease profiling, and others), end use (government institutes & academic centers, pharmaceutical & biotechnology, hospitals & clinics, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global RNA Analysis/Transcriptomics Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Agilent Technologies
- F. Hoffmann-La Roche
- Illumina
- QIAGEN
- Thermo Fisher Scientific
- Eurofins Scientific
- Merck KGaA
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
